Vident Advisory, LLC 10x Genomics, Inc. Transaction History
Vident Advisory, LLC
- $3.62 Trillion
- Q2 2024
A detailed history of Vident Advisory, LLC transactions in 10x Genomics, Inc. stock. As of the latest transaction made, Vident Advisory, LLC holds 11,999 shares of TXG stock, worth $194,023. This represents 0.01% of its overall portfolio holdings.
Number of Shares
11,999
Previous 7,828
53.28%
Holding current value
$194,023
Previous $294 Million
20.56%
% of portfolio
0.01%
Previous 0.01%
Shares
5 transactions
Others Institutions Holding TXG
# of Institutions
287Shares Held
94.9MCall Options Held
162KPut Options Held
107K-
Cathie Wood Ark Investment Management LLC | St. Petersburg, Fl10.8MShares$174 Million2.31% of portfolio
-
Vanguard Group Inc Valley Forge, PA10.2MShares$165 Million0.0% of portfolio
-
Black Rock Inc. New York, NY6.39MShares$103 Million0.0% of portfolio
-
Nikko Asset Management Americas, Inc.6.37MShares$103 Million1.67% of portfolio
-
Sumitomo Mitsui Trust Holdings, Inc.6.37MShares$103 Million0.1% of portfolio
About 10x Genomics, Inc.
- Ticker TXG
- Exchange NASDAQ
- Sector Healthcare
- Industry Health Information Services
- Shares Outstandng 95,046,400
- Market Cap $1.54B
- Description
- 10x Genomics, Inc., a life science technology company, develops and sells instruments, consumables, and software for analyzing biological systems in North America, Europe, the Middle East, Africa, China, and the Asia Pacific. The company provides chromium and chromium connect instruments, microfluidic chips, slides, reagents, and other consumabl...